Dear Colleague
The third update of concessionary prices were granted today for March 2023:
DrugPack SizeConcessionary Price
Bicalutamide 150mg tablets28£3.96
Cefalexin 250mg tablets28£2.86
Cefalexin 500mg capsules21£2.80
Cefalexin 500mg tablets21£2.80
Cinnarizine 15mg tablets84£5.40
Clarithromycin 125mg/5ml oral suspension70£4.99
Clarithromycin 250mg tablets14£4.80
Co-careldopa 12.5mg/50mg tablets90£4.00
Donepezil 10mg tablets28£1.35
Donepezil 5mg tablets28£1.35
Erythromycin 250mg gastro-resistant tablets28£3.24
Febuxostat 80mg tablets28£6.19
Flucloxacillin 250mg/5ml oral solution sugar free100£4.93
Ketoconazole 2% shampoo120£14.95
Lofepramine 70mg tablets56£13.53
Mometasone 0.1% ointment30£4.51
Nadolol 80mg tablets28£14.45
Phenoxymethylpenicillin 125mg/5ml oral solution100£9.99
Phenoxymethylpenicillin 125mg/5ml oral solution
sugar free
100£9.99
Phenoxymethylpenicillin 250mg/5ml oral solution100£10.50
Phenoxymethylpenicillin 250mg/5ml oral solution
sugar free
100£10.50
Rabeprazole 10mg gastro-resistant tablets28£5.76
Ropinirole 250microgram tablets12£5.64
Ropinirole 2mg tablets28£20.52
Trazodone 100mg capsules56£4.76
Trazodone 50mg capsules84£5.02
Valaciclovir 500mg tablets10£14.85
Venlafaxine 150mg modified-release capsules28£5.63
Venlafaxine 150mg modified-release tablets30£4.95
Zopiclone 7.5mg tablets28£1.61
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Contractor

As you will be aware, CPNI has been engaging with NICPLD on the Experiential Learning (EL) Programme over recent months and keeping contractors updated accordingly. Community pharmacy as a sector is supportive of EL and particularly welcomes the opportunity to encourage our students to pursue a career in community pharmacy. In order to do that, CPNI believes students need to have a positive EL placement with adequate support in a conducive environment. The pressures currently facing the community pharmacy network, in terms of workforce, workload and funding, are of such magnitude that CPNI would suggest that contractors consider their own situations objectively to decide if it will be feasible for their pharmacy to participate, and whether it is the right time for students to experience the harsh reality of community pharmacy. CPNI will remain supportive of the EL programme and engage with those involved, but we have to ensure that the programme is providing the right foundation for students and contractors to build the future of community pharmacy upon. Unfortunately, that is not currently the status and without significant investment the community pharmacy service is at real risk.

CPNI are aware that NICPLD are seeking availability from contractors for the dates they would be able to host EL placements and also seeking further providers to register with NICPLD. We also understand that contractors may previously have registered their interest in becoming an EL provider.

Given discussions at the most recent contractor meeting, contractors may consider deferring giving any further commitment at this time, including accepting any placements or returning any contracts/declarations, until such time that community pharmacy is equipped to offer students the experience of the sector they deserve.

Please do not hesitate to contact the CPNI office or your local CPNI Director if you have any further queries.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
Please see attached correspondence from the Department of Health outlining the plans for Phase 2 of the SRP claims process.
While the vast majority of eligible individuals captured in Phase 1 of the process, which was co-ordinated by the Health & Social Care Board (HSCB) on behalf of the DoH during 2021/22. Phase 2 guidance documentation and claim template have been developed to support the implementation of the SRP for Community Pharmacy.

If contractors identify there are further eligible individuals you need to claim for in the SRP Phase 2 process, please follow the guidance attached and complete the Phase 2 claim template for any remaining eligible individuals and return to SPPG dedicated email addresses available HERE. If you have assessed that you do not need to make an SRP Phase 2 claim return, please confirm this by email, quoting your Practice number on the subject line of the email and also adding “Nil Return” to the subject line of the email.

When the supporting information has been received and your claim has been checked/validated, SPPG will confirm the value of the SRP reimbursement to you and the date the payment will be processed. If you have any queries, please direct these by email to the StaffRecognitionPaymentQueries@hscni.net email address in the first instance.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
SPPG has issued a reminder to community pharmacies who are vaccinating care home residents as part of the Community Pharmacy Vaccination Service.

Care home residents are considered to be a priority group for spring COVID-19 booster vaccinations.  PHA has arranged that those community pharmacies vaccinating the care homes will receive priority in vaccine deliveries, if vaccines are ordered this week.

For the purposes of planning pharmacies will have paired with the care homes they plan to vaccinate and are asked to calculate approximate numbers of vaccines needed to complete the care home population. Pharmacies are also asked to allow an overage to facilitate walk in patients, and to expect vaccine delivery from Movianto in 3-5 days depending on weekends and Easter will restrict delivery options to pharmacies.

Contractors are asked to order the total number of vaccines needed to complete the care homes.  If orders are not placed this week this will impact on vaccine deliveries and will delay the onset of clinics in care homes post Easter. It is worth noting the pack size of Comirnaty Original/Omicron BA.4-5 is 60 (6x10dose vials) the vaccine expiry is 10 weeks from date of thaw.

If you have any queries relating to this correspondence please contact Greg Miller (Greg.Miller@hscni.net), Bronagh Ward (Bronagh.Ward@hscni.net) or Helen Parr (Helen.Parr@hscni.net).

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
Please see attached correspondence from the Strategic Planning and Performance Group outlining the plans for the service in this 2023/24 year and to seek an assurance in relation to service provided in 2022/23.

SUMMARY

  • Approximately 392 care homes are signed up to the CPCHSS service with their community pharmacy, which represents 82% of all RQIA registered nursing and residential care homes.
  • Pharmacies previously signed up to the 22/23 service will continue in line with the CPCHSS Service Specification for the 2023/24 year. 
  • The requirement of the service is that each pharmacy should undertake two care home visits each financial year, the first of which should be completed before the end of September 2023.
  • Service documentation and previously recorded ECHO training sessions are available to view on the BSO website HERE.
  • A review of a sample of completed medication audit support tools, has indicated that community pharmacists are identifying a broad range of medication related issues within care homes resulting in advice and support to improve medicines management systems within the care homes.

ACTION

  • Contractors should read the attached correspondence to ensure community pharmacy teams are aware of the Community Pharmacy Care Home Support Service Update.
  • Pharmacies previously signed up to the 22/23 service should return the attached proforma to your local office by Friday 21 April 2023.
  • For those pharmacies who have not signed up to the service during 22/23 but who now wish to participate in the 23/24 service, please return by email your completed contract to your local office by Friday 21 April 2023.
  • A service agreement form should be completed for every care home for which the pharmacy is providing the service and a copy should be retained in the pharmacy.

If you have any queries in relation to this service please contact Breege Brogan Breege.Brogan@hscni.net or Gillian Plant Gillian.Plant@hscni.net.

CPNI will provide you with further updates to the Community Pharmacy Care Home Support Service.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Contractor

Please see information from the CPNI Contractor meeting held on Thursday 23 March 2023.

Please do not hesitate to contact CPNI offices or your local CPNI Director representative should you require any additional information.

Yours sincerely

SENT ON BEHALF OF 
GERARD GREENE
Chief Executive